Latest News from Origin

Lintbells: Brave and Bold

Lintbells, which produces health products for pets, won the “Market Mover” category of┬áthe Growth Accelerator’s “Brave and Bold” awards. Congratulations to the Lintbells team!

Read more…

Apricus exit returns 2.5x

We invested in lifesciences business BioQuant, Apricus’ forerunner, in 2007, and again in 2008.

The company achieved a NASDAQ listing in 2009 and we sold our holding on the market over 2012 and 2013. We disposed of our shares in a spun-out subsidiary, Innovus Pharmaceuticals, on the US OTC market in Q1 this year, which completed our exit. Overall, the sales recouped 2.5x cash invested, representing a c.25% IRR over the holding period.

Origin CEO interviewed

Origin’s CEO, Tim de Vere Green, was recently interviewed by Anthony Miller of TechMarketView, regarding his experience of angel tech investing.

see article…

Vantage Power wins Shell Springboard

Vantage Power, our portfolio company developing retro-fit hybrid engines for buses, won the prestigious Shell Springboard competition earlier this week.

Read more…